Dynamics Group AG | WebDisclosure

PRESS RELEASE

published on 01/02/2026 at 08:00, 8 months 17 days ago

CEO transition at Neovii Pharmaceuticals: Frédéric Prince to succeed Christian Loss, effective January 1st, 2026
Frédéric Prince to succeed Christian Loss as CEO of Neovii Pharmaceuticals on January 1st, 2026. Dr. Loss retires after distinguished career. Dr. Prince brings extensive experience in research & development and commercial functions

CEO Transition Leadership Roles Neovii Pharmaceuticals Frédéric Prince Christian Loss
BRIEF

published on 12/24/2025 at 13:03, 8 months 25 days ago

DiNABIOS se félicite de l'adoption de la loi de modernisation de la FDA 3.0

Innovation Développement De Médicaments DiNABIOS Modernisation De La FDA Nouvelles Méthodologies D'approche
BRIEF

published on 12/24/2025 at 13:03, 8 months 25 days ago

DiNABIOS Welcomes FDA Modernization Act 3.0 Passage

Innovation Drug Development FDA Modernization DiNABIOS New Approach Methodologies
PRESS RELEASE

published on 12/24/2025 at 12:58, 8 months 25 days ago

DiNABIOS Applauds Historic U.S. Senate Passage of FDA Modernization Act 3.0, Advancing Human‑Relevant New Approach Methodologies (NAMs)
DiNABIOS celebrates U.S. Senate passage of FDA Modernization Act 3.0, promoting human-relevant NAMs for drug development and reducing animal testing

Drug Development DiNABIOS FDA Modernization Act 3.0 NAMs Animal Testing
BRIEF

published on 12/23/2025 at 14:41, 8 months 26 days ago

DiNAQOR présente une plateforme révolutionnaire pour l'administration de médicaments de précision.

Biotechnologie Thérapie Génique Médecine De Précision DiNAQOR Perfusion Loco-régionale
BRIEF

published on 12/23/2025 at 14:41, 8 months 26 days ago

DiNAQOR Introduces Breakthrough Platform for Precision Drug Delivery

Biotechnology Precision Medicine Gene Therapy DiNAQOR Loco-Regional Perfusion
PRESS RELEASE

published on 12/23/2025 at 14:36, 8 months 26 days ago

DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies
DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development

Advanced Therapies DiNAQOR Academic Partners Percutaneous Platform Organ-specific Delivery
BRIEF

published on 12/22/2025 at 14:55, 8 months 27 days ago

DiNAQOR Bolsters Leadership with Key Strategic Appointments

Biotechnology Leadership Changes Strategic Appointments Dr. Christian Thirion DiNAQOR AG
BRIEF

published on 12/22/2025 at 14:55, 8 months 27 days ago

DiNAQOR renforce son équipe dirigeante grâce à des nominations stratégiques clés

Biotechnologie Changements De Direction Nominations Stratégiques DiNAQOR AG Dr Christian Thirion
PRESS RELEASE

published on 12/22/2025 at 14:50, 8 months 27 days ago

DiNAQOR Strengthens Group Leadership with Strategic Appointments
DiNAQOR strengthens group leadership by appointing Dr. Christian Thirion as CEO of DiNATEQ AG and Dr. Josef El Andari as Chief Scientific Officer, reinforcing its focus on next-generation life science ventures

Biotechnology Life Science Strategic Appointments DiNAQOR Group Leadership

Published on 09/19/2026 at 00:55, 8 hours 43 minutes ago

Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 9 hours 48 minutes ago

Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 11 hours 38 minutes ago

Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 13 hours 3 minutes ago

Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 19 hours 8 minutes ago

AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE

Published on 09/19/2026 at 07:30, 2 hours 8 minutes ago

Hong Kong sets out initiatives to secure long-term development of pillar industries
Published on 09/18/2026 at 18:45, 14 hours 53 minutes ago

Holding(s) in Company
Published on 09/18/2026 at 18:44, 14 hours 54 minutes ago

EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:13, 15 hours 25 minutes ago

Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:09, 15 hours 29 minutes ago

Multi Units Luxembourg: NOTICE TO SHAREHOLDERS

View all EQS

Published on 09/18/2026 at 18:34, 15 hours 4 minutes ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 15 hours 4 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 18:10, 15 hours 28 minutes ago

Rapport semestriel 2026
Published on 09/18/2026 at 17:45, 15 hours 53 minutes ago

Press Release_Carrefour Bond_September 2026
Published on 09/18/2026 at 17:45, 15 hours 53 minutes ago

Communiqué de presse_Carrefour Bond_Septembre 2026

View all LES ECHOS COMFI WIRE

News